Q3 2024 Holdings
Filed 2024-11-14 | 27 holdings | $338.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences Inc(GILD) | COM | 375558103 | $30.1M | 359,025 | 8.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $29.7M | 574,057 | 8.8% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $18.8M | 664,859 | 5.6% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $17.9M | 120,485 | 5.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $15.9M | 286,803 | 4.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $15.9M | 325,953 | 4.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.8M | 215,884 | 4.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $15.3M | 17,299 | 4.5% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $15.2M | 14,476 | 4.5% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $15.1M | 376,315 | 4.4% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $14.6M | 557,937 | 4.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $13.1M | 117,500 | 3.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $12.1M | 378,453 | 3.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.8M | 518,677 | 3.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $10.5M | 83,756 | 3.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $10.1M | 396,388 | 3.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $9.5M | 105,767 | 2.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $8.3M | 186,623 | 2.4% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.2M | 876,009 | 2.4% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $8.0M | 390,622 | 2.4% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $7.6M | 172,876 | 2.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.5M | 89,863 | 2.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $7.4M | 160,947 | 2.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.1M | 798,137 | 1.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.3M | 207,896 | 1.6% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $5.1M | 385,172 | 1.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.9M | 97,300 | 1.2% |